N-Formyl Peptide Receptor 3 (FPR3) Departs from the Homologous FPR2/ALX Receptor with Regard to the Major Processes Governing Chemoattractant Receptor Regulation, Expression at the Cell Surface, and Phosphorylation

被引:51
|
作者
Rabiet, Marie-Josephe [1 ,2 ,3 ,4 ]
Macari, Laurence [1 ,2 ,3 ,4 ]
Dahlgren, Claes [5 ]
Boulay, Francois [1 ,2 ,3 ,4 ]
机构
[1] INSERM, U1036, F-38054 Grenoble, France
[2] CEA, DSV iRTSV, F-38054 Grenoble, France
[3] CNRS, ERL 5261, F-38054 Grenoble, France
[4] Univ Grenoble 1, F-38041 Grenoble, France
[5] Univ Gothenburg, Dept Rheumatol & Inflammat Res, S-41346 Gothenburg, Sweden
关键词
C5A ANAPHYLATOXIN RECEPTOR; BETA-ARRESTIN; DENDRITIC CELLS; BETA(2)-ADRENERGIC RECEPTOR; DIFFERENTIAL REGULATION; ACTIVATES NEUTROPHILS; ELICITED MACROPHAGES; CARBOXYL-TERMINUS; CLATHRIN ADAPTER; HL-60; CELLS;
D O I
10.1074/jbc.M111.244590
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Among human N-formyl peptide chemoattractant receptors, FPR2/ALX and FPR3 share the highest degree of amino acid identity (83%), and trigger similar cell responses upon ligand binding. Although FPR2/ALX is a promiscuous receptor, FPR3 has only one specific high affinity ligand, F2L, and a more restricted tissue/cell distribution. In this study, we showed that FPR2/ALX behaved as the prototypical receptor FPR1. The agonist-dependent phosphorylation used a hierarchical mechanism with a prominent role of Ser(329), Thr(332), and Thr(335). Phosphorylation of FPR2/ALX was essential for its desensitization but the lack of phosphorylation did not result in enhanced or sustained responses. In contrast, resting FPR3 displayed a marked level of phosphorylation, which was only slightly increased upon agonist stimulation. Another noticeable difference between the two receptors was their subcellular distribution in unstimulated cells. Although FPR2/ALX was evenly distributed at the plasma membrane FPR3 was localized in small intracellular vesicles. By swapping domains between FPR2/ALX and FPR3, we uncovered the determinants involved in the basal phosphorylation of FPR3. Experiments aimed at monitoring receptor-bound antibody uptake showed that the intracellular distribution of FPR3 resulted from a constitutive internalization that was independent of C terminus phosphorylation. Unexpectedly, exchanging residues 1 to 53, which encompass the N-terminal extracellular region and the first transmembrane domain, between FPR2/ALX and FPR3 switched localization of the receptors from the plasma membrane to intracellular vesicles and vice versa. A clathrin-independent, possibly caveolae-dependent, mechanism was involved in FPR3 constitutive internalization. The peculiar behavior of FPR3 most probably serves distinct physiological functions that remain largely unknown.
引用
收藏
页码:26718 / 26731
页数:14
相关论文
共 3 条
  • [1] Novel ureidopropanamide based N-formyl peptide receptor 2 (FPR2) agonists with potential application for central nervous system disorders characterized by neuroinflammation
    Stama, Madia Letizia
    Slusarczyk, Joanna
    Lacivita, Enza
    Kirpotina, Liliya N.
    Schepetkin, Igor A.
    Chamera, Katarzyna
    Riganti, Chiara
    Perrone, Roberto
    Quinn, Mark T.
    Basta-Kaim, Agnieszka
    Leopoldo, Marcello
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 141 : 703 - 720
  • [2] Functional N-Formyl Peptide Receptor2 (FPR2) Antagonists Based on the Ureidopropanamide Scaffold Have Potential To Protect Against Inflammation-Associated Oxidative Stress
    Stama, Madia L.
    Lacivita, Enza
    Kirpotina, Liliya N.
    Niso, Mauro
    Perrone, Roberto
    Schepetkin, Igor A.
    Quinn, Mark T.
    Leopoldo, Marcello
    CHEMMEDCHEM, 2017, 12 (22) : 1839 - 1847
  • [3] 4-Aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-ones as N-formyl peptide receptor 1 (FPR1) antagonists
    Kirpotina, Liliya N.
    Schepetkin, Igor A.
    Khlebnikov, Andrei I.
    Ruban, Olga I.
    Ge, Yunjun
    Ye, Richard D.
    Kominsky, Douglas J.
    Quinn, Mark T.
    BIOCHEMICAL PHARMACOLOGY, 2017, 142 : 120 - 132